Presolicitation Notice - Illumina NextSeq 2000 Sequencing System

Defense Health Agency · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

August 18, 2026
Response Due
Active
Status

Opportunity Overview

The Defense Health Agency Contracting Activity (DHACA) in Fort Detrick, MD intends to negotiate on a sole source basis (IAW RFO 12.201-1) with Illumina, Inc 5200 Illumina Way San Diego, CA 92122, as the only responsible source that can provide an Illumina NextSeq 2000 Sequencing System to replace the Illumina NextSeq 550 system that is approaching end-of-life status. This is a Presolicitation notice in accordance with RFO 5.101.

To support the mission of the Armed Forces Medical Examiner System (AFMES) and the Defense POW/MIA Accounting Agency (DPAA), AFMES-DNA OPS with the identification of missing service members from World War II, Korea, Vietnam, and the cold war as part of DoD’s past accounting missions. To meet the National Defense Authorization Act (NDAA) 2010 mandate for 200 annual identifications, AFMES- DNA OPS has developed, validated Next-Generation Sequencing (NGS) methods on Illumina platforms.

Due to the end-of-life status of the current NextSeq 550 systems and a significant increase in mission sample workload, a direct replacement is required. To maintain mission continuity, one (1) Illumina NextSeq 2000 Sequencing System is needed. This will allow for the seamless transfer of existing validated assays and provide the increased throughput necessary for identifying fallen service members.

The NextSeq 2000 is the direct, next-generation replacement for the laboratory's current, end-of-life Illumina sequencers. It offers backward compatibility with the existing validated assays while providing increased throughput (up to 120 Gb), faster run times (approximately 8-42 hours), and higher data quality (2'90% of bases >Q30). This is critical as the NGS sample workload has increased. Furthermore, the NextSeq 2000 offers future scalability, as it can be upgraded to another NextSeq System if mission demands increase further.

Switching to a different manufacturer's system would require complete re-development and re-validation of all sequencing assays, a...

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDefense Health Agency
CountryUnited States
CategoryGovernment Procurement
NAICS334516
PSC6515
PublishedAugust 03, 2026
Procurement stageRequest for Proposal (RFP)
Response dueAugust 18, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

MUSEUM EXHIBIT FABRICATIONS
Auto Stainer and Auto Cover Slipper
Hospital Communications Support
Preventive Maintenance for STERIS Small Steam Sterilizers and Single-Chamber Washer/Disinfectors
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract
Enterprise Dose Monitoring
European Healthcare Environmental Cleaning (HEC) Services

See every United States Government Procurement opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Government Procurement intelligence report in your inbox

A personalized report on United States Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.